Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Apyx Medical Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Surgical & Medical Instruments & Apparatus
No intraday reading yet this session.
APYX (Apyx Medical Corp) has 1 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
68 institutional managers report a position in Apyx Medical Corp worth $96.0M between them, filed on form 13F for the quarter ending 2026-06-30. 13 of them hold 80% of it, the largest being Royce & Associates LP at 15.31%.
43 more managers in the register
13 managers hold 80% of the $96.0M institutional base. The other 55 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via Royce & Associates LP, Essex Investment Management Co LLC, Legato Capital Management LLC +1 more · 15.31% of APYX, 14.16% of LGCY
via Nantahala Capital Management, LLC, AIGH Capital Management LLC, Caption Management, LLC · 15.29% of APYX, 14.52% of TLPH
via Nantahala Capital Management, LLC, AIGH Capital Management LLC, Marshall Wace LLP · 15.29% of APYX, 14.97% of ABEO
via Nantahala Capital Management, LLC, AIGH Capital Management LLC · 15.29% of APYX, 22.07% of ELUT
via Royce & Associates LP, AIGH Capital Management LLC, Archon Capital Management LLC +2 more · 15.31% of APYX, 9.03% of SOPH
via Royce & Associates LP, Caption Management, LLC, Marshall Wace LLP +4 more · 15.31% of APYX, 14.07% of INSG
Managers holding a meaningful stake in APYX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.